Results 141 to 150 of about 2,929 (206)

Comparative efficacy, safety and compliance with dual, triple and quadruple therapy as the first-line treatment regimens for <i>Helicobacter pylori</i> eradication: a systematic review and network meta-analysis. [PDF]

BMJ Open Gastroenterol
Taufiqqurrachman I, Syam AF, Maulahela H, Abdullah M, Matsumoto T, Miftahussurur M, Yamaoka Y.   +6 more
europepmc   +1 more source

Commentary: Efficacy and safety of vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for patients with <i>Helicobacter pylori</i> infection: a meta-analysis. [PDF]

Front Microbiol
Chen Liang A, Cruz Castillo Y, Beltrán Covarrubias SA.   +2 more
europepmc   +1 more source

Role of Vonoprazan-Amoxicillin Dual Therapy in Pediatric Refractory <i>Helicobacter Pylori</i> Infection in Children: Early Experience From A Single-Center Case Series. [PDF]

ACG Case Rep J
Cardenas Fernandez MC, Ruiz Arellanos K, Bonilla S.   +2 more
europepmc   +1 more source

Therapeutic advances and future directions in <i>Helicobacter pylori</i> eradication. [PDF]

Front Microbiol
Suresh V, Sreekumar A, Kumar A, Sadasivan S, Biswas R, Biswas L.   +5 more
europepmc   +1 more source

LC-MS/MS Method Development and Validation for Clinical Pharmacokinetics and Therapeutic Drug Monitoring of Potassium-Competitive Acid Blocker Vonoprazan-Based Triple Therapy for <i>H. pylori</i> in Human Plasma. [PDF]

Pharmaceuticals (Basel)
Al-Tannak NF, Hafez HM, Hemdan A, Aldasem A, Khadra I.   +4 more
europepmc   +1 more source

Optimizing acid-related disease management: insights into potassium-competitive acid blockers and proton pump inhibitors. [PDF]

Eur J Clin Pharmacol
Shang H, Mao H, Wang J, Tian X, Zheng K, Wang J.   +5 more
europepmc   +1 more source

Vonoprazan-amoxicillin dual therapy vs. proton pump inhibitor based dual therapy for Helicobacter pylori eradication: a meta-analysis. [PDF]

Front Med (Lausanne)
Lv Y, Zhou HH, Sun JG, Qin Y, Zhou BG.
europepmc   +1 more source

Exploratory Study on Efficacy and Safety of Minocycline-Based Dual Therapy for <i>Helicobacter pylori</i> Eradication. [PDF]

Pathogens
Gao W, Li J, Tian Y, Ge C, Wang C, Liu J, Li Y, Cheng H.   +7 more
europepmc   +1 more source

Lansoprazole as a possible trigger of restless legs syndrome with suspected periodic limb movement disorder in a hemodialysis patient: a case report. [PDF]

CEN Case Rep
Nakata H, Nishiwaki K.
europepmc   +1 more source

Beyond monotherapy by acid suppression: Reshaping the management of refractory gastroesophageal reflux disease. [PDF]

World J Gastroenterol
Zuo XY, Chen QQ.
europepmc   +1 more source